SIRT3 and metabolic dysfunction-associated steatotic liver disease: In HFD-induced NAFLD rats, the protein expression levels of sirtuin 3 (SIRT3), p-AMPK, and p-ACC were significantly higher in the livers of rats in the BBR treatment group, and the serum and liver lipid profiles and liver injury status improved.